SCHEMBL13587013

SCHEMBL13587013

Cc1ccc(C=C2C(=O)NC(=S)NC2=O)s1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 12/20 0.67
▸ MEN1 O00255 7/20 0.67
▸ ALPL P05186 1/20 0.67
▸ HSP90AA1 P07900 1/20 0.67
▸ ALPI P09923 1/20 0.67
▸ ALPG P10696 1/20 0.67
▸ G6PD P11413 1/20 0.67
▸ ALDH1A1 P00352 9/20 0.56
▸ MAPT P10636 9/20 0.56
▸ POLB P06746 6/20 0.56
▸ HPGD P15428 5/20 0.55
▸ LMNA P02545 2/20 0.55
▸ MAPK1 P28482 2/20 0.55
▸ NPC1 O15118 1/20 0.55
▸ TNFRSF1A P19438 1/20 0.55
▸ SMN1; SMN2 Q16637 1/20 0.55
▸ NPSR1 Q6W5P4 3/20 0.54
▸ PKM P14618 2/20 0.54
▸ TP53 P04637 1/20 0.54
▸ MCL1 Q07820 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6571064 0.80 MEN1 (1.00) KMT2AMEN1ALPLHSP90AA1ALPI
SCHEMBL13056365 0.75 PRF1 (0.60) KMT2AMEN1ALPLHSP90AA1ALPI
SCHEMBL5728059 0.75 EGFR (0.69) KMT2AMEN1ALDH1A1MAPTPOLB
SCHEMBL5728062 0.75 EGFR (0.69) KMT2AMEN1ALDH1A1MAPTPOLB
SCHEMBL4035641 0.75 KMT2A (0.65) KMT2AMEN1ALPLHSP90AA1ALPI
SCHEMBL14510515 0.73 ERBB2 (0.73) KMT2AMEN1ALDH1A1MAPTPOLB
SCHEMBL18882615 0.72 MEN1 (0.56) KMT2AMEN1ALPLHSP90AA1ALPI
SCHEMBL5989406 0.72 MAPT (0.44) KMT2AMEN1ALDH1A1MAPTPOLB
SCHEMBL13848481 0.71 KMT2A (0.60) KMT2AMEN1ALPLHSP90AA1ALPI
SCHEMBL6001533 0.71 LRRK2 (0.58) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8759384-B2 Oxo-imidazolyl compounds ASTEXPHRMACEUTICALS, INC. 2014-06-24 — — US disclosed
US-8759384-B2 Oxo-imidazolyl compounds ASTEXPHRMACEUTICALS, INC. 2014-06-24 — — US disclosed
US-20090298900-A1 Oxo-Imidazolyl Compounds ASTEXPHRMACEUTICALS, INC. 2009-12-03 — — US disclosed
US-20090298900-A1 Oxo-Imidazolyl Compounds ASTEXPHRMACEUTICALS, INC. 2009-12-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090298900-A1 Oxo-Imidazolyl Compounds GALE, CYP51A1, GNE KMT2A 2066/4885MEN1 2988/4885ALPL 58/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback